Transcriptomic analysis of the mode of action of the candidate anti-fouling compound di(1H-indol-3-yl)methane (DIM) on a marine biofouling species, the bryozoan Bugula neritina

Di(1H-indol-3-yl)methane (DIM) was previously suggested to be an environmentally friendly antifouling compound, but it was also reported that the compound was highly stable in natural seawater. The present study reported that 3 h DIM treatments at 4 mu g mL(-1) or higher concentration and 12 h DIM treatments at 2 mu g mL(-1) or higher concentration induced significant larval mortality and metamorphic abnormality in the bryozoan Bugula neritina. The bioassay results correlated with the dose-dependent up-regulation of HSP family proteins, proapoptotic proteins, ubiquitination protein, and the dose-dependent down-regulation of anti-apoptotic genes and developmental genes. Unexpectedly, genes involved in fatty acid biosynthesis and protein synthesis were upregulated in response to DIM treatment, but, in general, the effects of DIM on B. neritina larvae were comparable to that reported in human cancer cell lines. DIM also induced changes in steroid hormone biosynthesis genes in B. neritina larvae, leading to the concern that DIM might have long-term effects on marine lives. Overall, the present study suggested that application of DIM to the bryozoan larvae would trigger a major transcriptomic response, which might be linked to the observed larval mortality and abnormality. We suggest that application of DIM as an antifouling ingredient should be proceeded with great cautions.